CHERRY angiomas have been considerably extra prevalent and developed at a youthful age in people with neurofibromatosis type 1 (NF1), with genetic analyses suggesting these lesions could signify a beforehand unrecognised vascular manifestation of the situation.
The potential cross-sectional research included 259 individuals aged 15 years or older, comprising 102 people with confirmed NF1 and 157 controls. The epidemiological evaluation was performed at a French nationwide referral centre for neurofibromatoses between October 2020 and March 2021, adopted by histopathological, genomic, and cell-specific molecular analyses.
Cherry angiomas have been recognized in 48% of people with NF1 in contrast with 18% of controls. The affiliation remained after adjustment for age and intercourse and in propensity score-matched analyses.
The chances of getting a cherry angioma have been additionally greater amongst people with NF1 (odds ratio: 4.26; 95% CI: 2.44–7.56).
NF1 Variants Recognized in Lesions
The researchers investigated the organic foundation of the affiliation by analysing cherry angiomas from people with NF1 and wholesome volunteers.
Somatic NF1 loss-of-function second-hit variants have been recognized in 26 of 39 NF1-associated cherry angiomas (67%), whereas no such variants have been recognized in management lesions. This indicated biallelic NF1 inactivation throughout the NF1-associated lesions.
Genomic profiling additionally recognized co-occurring activating variants, with GNAQ among the many most steadily noticed. Cell-specific sequencing indicated that NF1 second hits arose predominantly in endothelial cells and telocytes, with greater variant allele frequencies noticed in endothelial cells.
Potential Vascular Manifestation of NF1
Immunofluorescence evaluation demonstrated elevated phosphoextracellular signal-regulated kinase signalling within the vascular cell populations carrying NF1 alterations, offering additional proof of pathway activation throughout the lesions.
The researchers steered that the findings lengthen understanding of NF1-associated manifestations past neural crest-derived tissues and help cherry angiomas as a possible mannequin for NF1-related vasculopathy.
Though the research was cross-sectional, the mixture of epidemiological and mechanistic findings means that the elevated incidence of cherry angiomas in people with NF1 could have a organic foundation quite than representing an incidental scientific commentary.
The findings may broaden the recognised spectrum of NF1-associated neoplasms and supply a mannequin for investigating vascular illness related to NF1 loss.
Reference
Fertitta L et al. Cherry angiomas in people with neurofibromatosis kind. JAMA Dermayol. 2026;DOI:10.1001/jamadermatol.2026.2933.
Featured picture: Olya on Adobe Inventory
